Selenium for preventing cancer

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 3, 2014, Pages

  Vinceti, Marco ^a   Dennert, Gabriele ^b   Crespi, Catherine M ^c   Zwahlen, Marcel ^d   Brinkman, Maree ^e   Zeegers, Maurice P A ^f   Horneber, Markus ^g   D'Amico, Roberto ^a   Del Giovane, Cinzia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF APPLIED SCIENCES AND ARTS DORTMUND   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g KLINIKUM NÜRNBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM; TRACE ELEMENT;

ALOPECIA; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; DERMATITIS; DIET SUPPLEMENTATION; DISEASE SEVERITY; HUMAN; LIVER CANCER; LUNG CANCER; NON INSULIN DEPENDENT DIABETES MELLITUS; NON MELANOMA SKIN CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; RISK REDUCTION; SELENIUM BLOOD LEVEL; SEX DIFFERENCE; STOMACH CANCER; SYSTEMATIC REVIEW; CASE CONTROL STUDY; FEMALE; MALE; META ANALYSIS; NEOPLASM; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK;

CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; NEOPLASMS; OBSERVATIONAL STUDY AS TOPIC; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELENIUM; SEX FACTORS; TRACE ELEMENTS;

EID: 84903630397     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005195.pub3     Document Type: Review

References (325)

1. Agalliu I, Kirsh VA, Kreiger N, Soskolne CL, Rohan TE. Oxidative balance score and risk of prostate cancer: results from a case-cohort study. Cancer Epidemiology 2011;35(4):353-61.
2. Akbaraly NT, Arnaud J, Hininger-Favier I, Gourlet V, Roussel AM, Berr C. Selenium and mortality in the elderly: results from the EVA study. Clinical Chemistry 2005;51(11):2117-23.
3. Algotar AM, Stratton MS, Ahmann FR, et al.Phase III clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. The Prostate 2013;73:328-35.
4. Allen NE. Reply to B Bekaert and MP Rayman. American Journal of Clinical Nutrition 2009;89(4):1277.
5. Allen NE, Appleby PN, Roddam AW, Tjonneland A, Johnsen NF, Overvad K, et al.European Prospective Investigation into Cancer and Nutrition. Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). American Journal of Clinical Nutrition 2008;88(6):1567-75.
6. Bates CJ, Hamer M, Mishra GD. Redox-modulatory vitamins and minerals that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of people aged 65 years and over. British Journal of Nutrition 2011;105(1):123-32. [: EPI_EU_Bates 2011]
7. Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Archive of Internal Medicine 2008;168(4):404-10.
8. Brooks JD, Metter EJ, Chan DW, Sokoll LJ, Landis P, Nelson WG, et al.Plasma selenium level before diagnosis and the risk of prostate cancer development. The Journal of Urology 2001;166(6):2034-8.
9. Clark L, Graham G, Bray J. Nonmelanoma skin cancer and plasma selenium: a prospective cohort study. American Journal of Epidemiology 1985;122(3):528.
10. Coates RJ. Cancer risk in relation to serum levels of selenium, retinol, and copper. Dissertation Abstract International (Sci) 1987; Vol. 47, issue 12:4836.
11. Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF. Serum levels of selenium and retinol and the subsequent risk of cancer. American Journal of Epidemiology 1988;128(3):515-23.
12. Combs GF Jr, Clark LC, Turnbull BW, Graham GF, Smith CL, Sanders B Jr, et al.Low plasma selenium (Se) predicts the 24 month incidence of squamous cell carcinoma of the skin in a cancer prevention trial. FASEB 1993; Vol. 7, issue 3:A278.
13. Comstock GW, Alberg AJ, Huang HY, Wu K, Burke AE, Hoffman SC, et al.The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiology, Biomarkers & Prevention 1997;6(11):907-16.
14. Dong LM, Kristal AR, Peters U, Schenk JM, Sanchez CA, Rabinovitch PS, et al.Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutrition and Cancer 2008;60(1):39-48.
15. Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R, Schussler N, Stephenson HE Jr. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes and Control 1998;9(1):89-97.
16. Dreno B, Euvrard S, Frances C, Moyse D, Nandeuil A. Effect of selenium intake on the prevention of cutaneous epithelial lesions in organ transplant recipients. European Journal of Dermatology 2007;17(2):140-5.
17. Epplein M, Franke AA, Cooney RV, Morris JS, Wilkens LR, Goodman MT, et al.Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study. Cancer Epidemiology, Biomarkers & Prevention 2009;18(7):1962-70.
18. Gill JK, Franke AA, Steven MJ, Cooney RV, Wilkens LR, Le Marchand L, et al.Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control 2009;20(7):1161-71.
19. Kolonel LN, 5P01CA033619-20 . Epidemiologic studies of diet and cancer in Hawaii. http://cancercontrol.cancer.gov/grants/abstract.asp?ApplID=6805844 (accessed 6 April 2011).
20. Fex G, Pettersson B, Akesson B. Low plasma selenium as a risk factor for cancer death in middle-aged men. Nutrition and Cancer 1987;10(4):221-9.
21. Fujishima Y, Ohsawa M, Itai K, Kato K, Tanno K, Turin TC, et al.Serum selenium levels are inversely associated with death risk among hemodialysis patients. Nephrology, Dialysis, Transplantation 2011;26(10):3331-8.
22. Garland M, Morris JS, Stampfer MJ, Colditz GA, Spate VL, Baskett CK, et al.Prospective study of toenail selenium levels and cancer among women. Journal of the National Cancer Institute 1995;87(7):497-505.
23. Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE, Willett WC. A prospective study of selenium status and breast cancer risk. JAMA 1990;264(9):1128-31.
24. Glattre E, Thomassen Y, Thoresen SO, Haldorsen T, Lund-Larsen PG, Theodorsen L, et al.Prediagnostic serum selenium in a case-control study of thyroid cancer. International Journal of Epidemiology 1989;18(1):45-9.
25. Goodman GE, Schaffer S, Bankson DD, Hughes MP, Omenn GS, The Carotene and Retinol Efficacy Trial (CARET) Co-Investigators. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention 2001;10(10):1069-76.
26. Grundmark B, Zethelius B, Garmo H, Holmberg L. Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up. BMC Cancer 2011;11:431.
27. Hartman TJ, Albanes D, Pietinen P, Hartman AM, Rautalahti M, Tangrea JA, et al.The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiology, Biomarkers & Prevention 1998;7(4):335-40.
28. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, et al.Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. Journal of the National Cancer Institute 2000;92(24):2018-23.
29. Hotaling JM, Wright JL, Pocobelli G, Bhatti P, Porter MP, White E. Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study. The Journal of Urology 2011;185(4):1210-5.
30. Kabuto M, Imai H, Yonezawa C, Neriishi K, Akiba S, Kato H, et al.Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiology, Biomarkers & Prevention 1994;3(6):465-9.
31. Karagas MR, Greenberg ER, Nierenberg D, Stukel TA, Morris JS, Stevens MM, et al.Risk of squamous cell carcinoma of the skin in relation to plasma selenium, alpha-tocopherol, beta-carotene, and retinol: a nested case-control study. Cancer Epidemiology, Biomarkers & Prevention 1997;6(1):25-9.
32. Hakama M, Aaran RK, Alfthan G, Aromaa A, Hakulinen T, Knekt P, et al.Linkage of serum sample bank and cancer registry in epidemiological studies. Progress in Clinical and Biological Research, v. 346. New York: Wiley-Liss, 1990:169-78.
33. Knekt P, Aromaa A, Alfthan G, Maatela J, Hakama M, Hakulinen T, et al.Re: Prospective study of serum micronutrients and ovarian cancer. Journal of the National Cancer Institute 1996;88(19):1408.
34. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, Hakama M, et al.Serum selenium and subsequent risk of cancer among Finnish men and women. Journal of the National Cancer Institute 1990;82(10):864-8.
35. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, Teppo L, et al.Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. International Journal of Cancer 1988;42(6):846-50.
36. Knekt P, Jarvinen R, Seppanen R, Rissanen A, Aromaa A, Heinonen OP, et al.Dietary antioxidants and the risk of lung cancer. American Journal of Epidemiology 1991;134(5):471-9.
37. Knekt P, Marniemi J, Teppo L, Heliovaara M, Aromaa A. Is low selenium status a risk factor for lung cancer?. American Journal of Epidemiology 1998;148(10):975-82.
38. Kok FJ, De Bruijn AM, Hofman A, Valkenburg HA. Selenium status and chronic disease mortality: Dutch epidemiological findings. International Journal of Epidemiology 1987a;16(2):329-32.
39. Kok FJ, De Bruijn AM, Hofman A, Vermeeren R, Valkenburg HA. Is serum selenium a risk factor for cancer in men only?. American Journal of Epidemiology 1987b;125(1):12-6.
40. Kornitzer M, Valente F, De Bacquer D, Neve J, De Backer G. Serum selenium and cancer mortality: a nested case-control study within an age- and sex-stratified sample of the Belgian adult population. European Journal of Clinical Nutrition 2004;58(1):98-104.
41. Kromhout D. Essential micronutrients in relation to carcinogenesis. American Journal of Clinical Nutrition 1987;45(5 Suppl):1361-7.
42. Li W, Zhu Y, Yan X, Zhang Q, Li X, Ni Z, et al.The prevention of primary liver cancer by selenium in high risk populations. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine] 2000;34(6):336-8. [: Li 2000]
43. Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, Stampfer MJ, et al.Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Research 2005a;65(6):2498-504.
44. Li H, Stampfer MJ, Giovannucci EL, Morris JS, Willett WC, Gaziano JM, et al.A prospective study of plasma selenium levels and prostate cancer risk. Journal of the National Cancer Institute 2004;96(9):696-703.
45. Li H, Stampfer MJ, Giovannucci EL, Morris JS, Willett WC, Gaziano JM, et al.Plasma selenium levels associated with subsequent risk of prostate cancer. American Journal of Urology Review 2005b;3(1):28-34.
46. Marshall JR, Tangen CM, Sakr WA, Wood DP Jr, Berry DL, Klein EA, et al.Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prevention Research 2011;4:1761-9.
47. Heinen MM, Hughes MC, Ibiebele TI, Marks GC, Green AC, van der Pols JC. Intake of antioxidant nutrients and the risk of skin cancer. European Journal of Cancer 2007;43(18):2707-16.
48. McNaughton SA, Marks GC, Gaffney P, Williams G, Green AC. Antioxidants and basal cell carcinoma of the skin: a nested case-control study. Cancer Causes and Control 2005;16(5):609-18.
49. van der Pols JC, Heinen MM, Hughes MC, Ibiebele TI, Marks GC, Green AC. Serum antioxidants and skin cancer risk: an 8-year community-based follow-up study. Cancer Epidemiology, Biomarkers & Prevention 2009;18(4):1167-73.
50. Batieha AM, Armenian HK, Norkus EP, Morris JS, Spate VE, Comstock GW. Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiology, Biomarkers & Prevention 1993;2(4):335-9.
51. Breslow RA, Alberg AJ, Helzlsouer KJ, Bush TL, Norkus EP, Morris JS, et al.Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, beta-carotene, lycopene, alpha-tocopherol, and selenium. Cancer Epidemiology, Biomarkers & Prevention 1995;4(8):837-42.
52. Burney PG, Comstock GW, Morris JS. Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. American Journal of Clinical Nutrition 1989;49(5):895-900.
53. Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW. Prospective study of serum micronutrients and ovarian cancer. Journal of the National Cancer Institute 1996;88(1):32-7.
54. Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Research 1989;49(21):6144-8.
55. Ko W. The Associations of Serologic Precursors and the Anatomic-Site Specific Incidence of Colon Cancer. Baltimore, MD: John Hopkins University, 1994.
56. Menkes MJ. Vitamins A, E, selenium and risk of lung cancer. Dissertation Abstract International (Sci) 1986a; Vol. 46, issue 11:3807.
57. Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. New England Journal of Medicine 1986b;315(20):1250-4.
58. Schober SE. Vitamin A, vitamin E, selenium, and colon cancer risk. Dissertation Abstract International (Sci) 1986; Vol. 46, issue 11:3808.
59. Schober SE, Comstock GW, Helsing KJ, Salkeld RM, Morris JS, Rider AA, Brookmeyer R. Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk. American Journal of Epidemiology 1987;126(6):1033-41.
60. Zheng W, Blot WJ, Diamond EL, Norkus EP, Spate V, Morris JS, et al.Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. Cancer Research 1993;53(4):795-8.
61. Michaud DS, Hartman TJ, Taylor PR, Pietinen P, Alfthan G, Virtamo J, et al.No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiology, Biomarkers & Prevention 2002;11(11):1505-6.
62. Michaud DS, De Vivo I, Morris JS, Giovannucci E. Toenail selenium concentrations and bladder cancer risk in women and men. British Journal of Cancer 2005;93(7):804-6.
63. Nomura A, Heilbrun LK, Morris JS, Stemmermann GN. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. Journal of the National Cancer Institute 1987;79(1):103-8.
64. Nomura AMY, Lee J, Stemmermann GN, Combs GF Jr. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention 2000;9(9):883-7.
65. Clark L, Krongrad A, Dalkin B, Witherington R, Herlong H, Carpenter D. Decreased incidence of prostate cancer with selenium supplementation: 1983-96 results of a double-blind cancer prevention trial. European Journal of Cancer Prevention 1997; Vol. 6, issue 5:497-8.
66. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, et al.Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA 1996;276(24):1957-63.
67. Clark LC, Dalkin B, Krongrad A, Combs GF, Turnbull BW, Slate EH, et al.Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. British Journal of Urology 1998;81(5):730-4.
68. Clark LC, UARIZ-CA49764 NCI-P89-0003. Double-blind, randomized trial of selenium-enriched brewer's yeast vs brewer's yeast placebo for the prevention of skin cancer in patients with a history of squamous or basal cell skin cancer (Summary Last Modified 05/91). http://www.cancer.gov. National Cancer Institute, (accessed 1 March 2004).
69. Combs GF, Clark LC, Turnbull BW. Reduction of cancer mortality and incidence by selenium supplementation. Medizinische Klinik 1997;92(Suppl 3):42-5.
70. Combs GFJr, Clark LC, Turnbull BW. Reduction of cancer risk with an oral supplement of selenium. Biomedical and Environmental Sciences 1997;10(2-3):227-34.
71. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, et al.Nutritional Prevention of Cancer Study Group. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU International 2003b;91(7):608-12.
72. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, et al.Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiology, Biomarkers & Prevention 2002;11(7):630-9.
73. Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, et al.Nutritional Prevention of Cancer Study Group. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. Journal of the National Cancer Institute 2003a;95(19):1477-81.
74. Marshall JR, 5R01CA049764-15 . Nutritional Prevention of Cancer. http://crisp.cit.nih.gov (accessed 1 March 2004).
75. Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR. Selenium supplementation and lung cancer incidence: an update of the Nutritional Prevention of Cancer Trial. Cancer Epidemiology, Biomarkers & Prevention 2002;11(11):1285-91.
76. Reid ME, Duffield-Lillico AJ, Slate E, Natarajan N, Turnbull B, Jacobs E, et al.The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutrition and Cancer 2008;60(2):155-63.
77. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, et al.Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Annals of Internal Medicine 2007;147(4):217-23.
78. Overvad K, Wang DY, Olsen J, Allen DS, Thorling EB, Bulbrook RD, Hayward JL. Selenium in human mammary carcinogenesis: a case-cohort study. European Journal of Cancer 1991;27(7):900-2.
79. Peleg I, Morris S, Hames CG. Is serum selenium a risk factor for cancer?. Medical Oncology and Tumor Pharmacotherapy 1985;2(3):157-63.
80. Persson-Moschos ME, Stavenow L, Akesson B, Lindgarde F. Selenoprotein P in plasma in relation to cancer morbidity in middle-aged Swedish men. Nutrition and Cancer 2000;36(1):19-26.
81. Peters U, Foster CB, Chatterjee N, Schatzkin A, Reding D, Andriole GL, et al.Serum selenium and risk of prostate cancer - a nested case-control study. American Journal of Clinical Nutrition 2007;85(1):209-17.
82. Asgari MM, Maruti SS, Kushi LH, White E. Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Archives of Dermatology 2009;145(8):879-82.
83. Peters U, Littman AJ, Kristal AR, Patterson RE, Potter JD, White E. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control 2008;19(1):75-87.
84. Ratnasinghe D, Tangrea JA, Forman MR, Hartman T, Gunter EW, Qiao YL, et al.Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes and Control 2000;11(2):129-35.
85. Reid ME, Duffield-Lillico AJ, Slate E, Natarajan N, Turnbull B, Jacobs E, et al.The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutrition and Cancer 2008;60(2):155-63.
86. Ringstad J, Jacobsen BK, Tretli S, Thomassen Y. Serum selenium concentration associated with risk of cancer. Journal of Clinical Pathology 1988;41(4):454-7.
87. Sakoda LC, Graubard BI, Evans AA, London WT, Lin WY, Shen FM, et al.Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. International Journal of Cancer 2005;115(4):618-24.
88. Salonen JT, Alfthan G, Huttunen JK, Puska P. Association between serum selenium and the risk of cancer. American Journal of Epidemiology 1984;120(3):342-9.
89. Salonen JT, Salonen R, Lappetelainen R, Maenpaa PH, Alfthan G, Puska P. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. British Medical Journal (Clinical Research Edition) 1985;290(6466):417-20.
90. Cook ED. Selenium and Vitamin E Cancer Prevention Trial - this one's for us. Journal of the National Medical Association 2002;94(9):856-8.
91. Cook ED, Moody-Thomas S, Anderson KB, Campbell R, Hamilton SJ, Harrington JM, et al.Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Clinical Trials 2005;2(5):436-42.
92. DeFrancesco L. Prostate cancer prevention trial launched. Nature Medicine 2001;7(10):1076.
93. Dunn BK, Ryan A, Ford LG. Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention. Recent Results in Cancer Research 2009;181:183-93.
94. FDA . Largest-ever prostate cancer prevention trial. FDA Consumer 2001;35(5):8.
95. Ford LG, Minasian LM, McCaskill-Stevens W, Pisano ED, Sullivan D, Smith RA. Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA: A Cancer Journal for Clinicians 2003;53(2):82-101.
96. Hoque A, Albanes D, Lippman SM, Spitz MR, Taylor PR, Klein EA, et al.Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes and Control 2001;12(7):627-33.
97. Kardinal C, Brooks J. Ochsner Cancer Institute studies vitamin E and selenium as prostate cancer prevention agents. Ochsner Journal 2003;5(2):51.
98. Klein EA. Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and vitamin E cancer prevention trial. Recent Results in Cancer Research 2003;163:212-25.
99. Klein EA. Selenium and vitamin E cancer prevention trial. Annals of the New York Academy of Sciences 2004;1031:234-41.
100. Klein EA, Atkins MB, Walther P, Klotz L, SWOG-S000 . Phase III randomized study of selenium and vitamin E for the prevention of prostate cancer (SELECT trial). http://clinicaltrials.gov/ (accessed 12 January 2004).
101. Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR, et al.The selenium and vitamin E cancer prevention trial. World Journal of Urology 2003;21(1):21-7.
102. Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al.Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306(14):1549-56.
103. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, et al.SELECT: The Selenium and Vitamin E Cancer Prevention Trial: rationale and design. Prostate Cancer and Prostatic Diseases 2000;3(3):145-51.
104. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, et al.SELECT: the next prostate cancer prevention trial. Selenium and vitamin E cancer prevention trial. Journal of Urology 2001;166(4):1311-5.
105. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, et al.SELECT: the selenium and vitamin E cancer prevention trial. Urologic Oncology 2003;21(1):59-65.
106. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, et al.Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Journal of the National Cancer Institute 2005;97(2):94-102.
107. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al.Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301(1):39-51.
108. Lotan Y, Goodman PJ, Youssef RF, Svatek RS, Shariat SF, Tangen CM, et al.Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. Journal of Urology 2012;187(6):205-10.
109. Miller M. Enrollment begins for largest-ever prostate cancer prevention trial. Journal of the National Cancer Institute 2001;93(15):1132.
110. Pak RW, Lanteri VJ, Scheuch JR, Sawczuk IS. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial. Integrative Cancer Therapies 2002;1(4):338-44.
111. South West Oncology Group. Selenium and Vitamin E Cancer Prevention Trial (SELECT). http://www.controlled-trials.com/mrct/trial/SELENIUM/1059/42795.html (accessed 16 April 2004).
112. South West Oncology Group. Selenium and Vitamin E in preventing prostate cancer. http://www.controlled-trials.com/mrct/trial/SELENIUM/1059/32859.html. Southwest Oncology Group, (accessed 16 April 2004).
113. Tangen CM, Goodman PJ, Crowley JJ, Thompson IM. Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials. Journal of Urology 2004;171(2 Pt 2):S64-7.
114. Tom J. SELECT (opportunity for prostate cancer prevention). Hawaii Medical Journal 2002;61(6):126-9.
115. Steevens J, Van den Brandt PA, Goldbohm RA, Schouten LJ. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenterology. 138. W.B. Saunders (Independence Square West, Philadelphia PA 19106-3399, United States), 2010; Vol. 138, issue 5:1704-13.
116. Steinbrecher A, Meplan C, Hesketh J, Schomburg L, Endermann T, Jansen E, et al.Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiology, Biomarkers & Prevention. 19. American Association for Cancer Research Inc. (615 Chestnut Street, 17th Floor, Philadelphia PA 19106-3483, United States), 2010; Vol. 19, issue 11:2958-68.
117. Suadicani P, Hein HO, Gyntelberg F. Serum selenium level and risk of lung cancer mortality: a 16-year follow-up of the Copenhagen Male Study. The European Respiratory Journal 2012;39(6):1443-8.
118. Thomson CA, Neuhouser ML, Shikany JM, Caan BJ, Monk BJ, Mossavar-Rahmani Y, et al.The role of antioxidants and vitamin A in ovarian cancer: results from the Women's Health Initiative. Nutrition and Cancer 2008;60(6):710-9.
119. Zeegers MPA, Goldbohm RA, Bode P, van den Brandt PA. Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiology, Biomarkers & Prevention 2002;11(11):1292-7.
120. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Dorant E, Hermus RJ, et al.A prospective cohort study on selenium status and the risk of lung cancer. Cancer Research 1993a;53(20):4860-5.
121. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Dorant E, Hermus RJ, et al.A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. Journal of the National Cancer Institute 1993b;85(3):224-9.
122. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Dorant E, Hermus RJ, et al.Toenail selenium levels and the risk of breast cancer. American Journal of Epidemiology 1994;140(1):20-6.
123. van den Brandt PA, Zeegers MPA, Bode P, Goldbohm RA. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiology, Biomarkers & Prevention 2003;12(9):866-71.
124. van Noord PAH, Collette HJA, Maas MJ, de Waard F. Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project. International Journal of Epidemiology 1987;16(2):318-22.
125. Virtamo J, Valkeila E, Alfthan G, Punsar S, Huttunen JK, Karvonen MJ. Serum selenium and risk of cancer. A prospective follow-up of nine years. Cancer 1987;60(2):145-8.
126. Walter RB, Brasky TM, Milano F, White E. Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study. Cancer Epidemiology, Biomarkers & Prevention 2011;20(10):2298-308.
127. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, et al.Prospective study of serum selenium levels and incident esophageal and gastric cancers. Journal of the National Cancer Institute 2000;92(21):1753-63.
128. Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, et al.Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. American Journal of Clinical Nutrition 2004;79(1):80-5.
129. Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, et al.Prediagnostic serum selenium and risk of cancer. Lancet 1983;2(8342):130-4.
130. Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, et al.Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. Journal of the National Cancer Institute 1998;90(16):1219-24.
131. Li WG. [Preliminary observations on effect of selenium yeast on high risk populations with primary liver cancer]. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine] 1992;26(5):268-71.
132. Yu S, Li W, Zhu Y. Chemoprevention of Liver Cancer. CCPC-93: Second International Cancer Chemo Prevention Conference, April 28-30, 1993, Berlin (Meeting Abstract) 1993.
133. Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN, et al.A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biological Trace Element Research 1991;29(3):289-94.
134. Li WG. [Preliminary observations on effect of selenium yeast on high risk populations with primary liver cancer]. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine] 1992;26(5):268-71.
135. Yu SY, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biological Trace Element Research 1997;56(1):117-24. [MEDLINE: 15873]
136. Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN, et al.A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biological Trace Element Research 1991;29(3):289-94.
137. Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. American Journal of Epidemiology 1999;150(4):367-74.
138. Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, Steinmetz KA, et al.Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Research 1993;53(18):4230-7.
139. Brock KE, Gridley G, Morris JS, Willett WC. Serum selenium level in relation to in situ cervical cancer in Australia. Journal of the National Cancer Institute 1991;83(4):292-3.
140. Chen Q. [Protective effects of selenium, zinc and copper on lung cancer]. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine] 1988;22(4):221-4.
141. Chen K, Qiu JL, Sui LM, Yu WP, Wang JY, Zhang LJ. Nutrient intake and gastric cancer in residents of Zhoushan Islands, China. Digestive and Liver Disease 2003;35(12):912-3.
142. Connelly-Frost A, Poole C, Satia JA, Kupper LL, Millikan RC, Sandler RS. Selenium, folate, and colon cancer. Nutrition and Cancer 2009;61(2):165-78.
143. Costello AJ. A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: rationale, recruitment, and design issues. Urology 2001;57(4 Suppl 1):182-4.
144. Criqui MH, Bangdiwala S, Goodman DS, Blaner WS, Morris JS, Kritchevsky S, et al.Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study. Annals of Epidemiology 1991;1(5):385-93.
145. Cui Y, Vogt S, Olson N, Glass AG, Rohan TE. Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer. Cancer Epidemiology, Biomarkers & Prevention 2007;16(8):1682-5.
146. Davies TW, Treasure FP, Welch AA, Day NE. Diet and basal cell skin cancer: results from the EPIC-Norfolk cohort. British Journal of Dermatology 2002;146(6):1017-22.
147. Fleshner N, CAN-CNIC-PRP1 . Phase II randomized study of vitamin E, selenium, and soy protein isolate in patients with high-grade prostatic intraepithelial neoplasia. http://www.cancer.gov (accessed 1 April 2004).
148. Hagmar L, Linden K, Nilsson A, Norrving B, Akesson B, Schutz A, et al.Cancer incidence and mortality among Swedish Baltic Sea fishermen. Scandinavian Journal of Work, Environment and Health 1992;18(4):217-24.
149. Harris Holly R, Brgkvist L, Wolk A. Selenium intake and breast cancer mortality in a cohort of Swedish women. Breast Cancer Research and Treatment 2012;134(3):1269-77.
150. Hartman TJ, Taylor PR, Alfthan G, Fagerstrom R, Virtamo J, Mark SD, et al.Toenail selenium concentration and lung cancer in male smokers (Finland). Cancer Causes & Control 2002;13(10):923-8.
151. Huzarski T, Byrski T, Gronwald J, Kowalska E, Zajaczek S, Gorski B, et al.A lowering of breast and ovarian cancer risk in women with a BRCA1 mutation by selenium supplementation of diet. Hereditary Cancer in Clinical Practice 2006;4(1):58.
152. Joniau S, Goeman L, Roskams T, Lerut E, Oyen R, Van PH. Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia. Urology 2007;69(6):1102-6.
153. Kellen E, Zeegers MP, Bruckers L, Buntinx F. The investigation of a geographical cluster of bladder cancer. Acta Clinica Belgica 2008;63(5):313-20.
154. Kilander L, Berglund L, Boberg M, Vessby B, Lithell H. Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men. International Journal of Epidemiology 2001;30(5):1119-26.
155. Knekt P, Reunanen A, Aromaa A, Heliovaara M, Hakulinen T, Hakama M. Serum cholesterol and risk of cancer in a cohort of 39, 000 men and women. Journal of Clinical Epidemiology 1988;41(6):519-30.
156. Knekt P, Aromaa A, Maatela J, Aaran RK, Nikkari T, Hakama M, et al.Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. American Journal of Epidemiology 1988;127(1):28-41.
157. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, Nikkari T, et al.Serum micronutrients and risk of cancers of low incidence in Finland. American Journal of Epidemiology 1991;134(4):356-61.
158. Kok FJ, van Duijn CM, Hofman A, Vermeeren R, De Bruijn AM, Valkenburg HA. Micronutrients and the risk of lung cancer (letter). New England Journal of Medicine 1987c;316:1416.
159. Kune G, Watson L. Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene. Nutrition and Cancer 2006;56(1):11-21.
160. Kuroda M, Imura T, Morikawa K, Hasegawa T. Decreased serum levels of selenium and glutathione peroxidase activity associated with aging, malignancy and chronic hemodialysis. Trace Elements in Medicine 1988;5(3):97-103.
161. Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, et al.Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. Journal of the National Cancer Institute 2007;99(10):754-64.
162. Le Marchand L, Saltzman BS, Hankin JH, Wilkens LR, Franke AA, Morris SJ, et al.Sun exposure, diet, and melanoma in Hawaii Caucasians. American Journal of Epidemiology 2006;164(3):232-45.
163. Li H, Li HQ, Wang Y, Xu HX, Fan WT, Wang ML, et al.An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. Chinese Medical Journal 2004;117(8):1155-60.
164. Limburg PJ, Wei W, Ahnen DJ, Qiao Y, Hawk ET, Wang G, et al.Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 2005;129(3):863-73.
165. NCI-OH95-C-N026NCI-P00-0157 . Pilot randomized chemoprevention study of selenium and celecoxib, alone or in combination, in patients with esophageal squamous dysplasia who are residing in Linxian, People's Republic of China. http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=67930&version=HealthProfessional&protocolsearchid=5845119 (accessed 25 February 2009).
166. Neuhouser ML, Wassertheil-Smoller S, Tomson C, Aragaki A, Anderson GL, Manson JE, et al.Multivitamin use and risk of cancer and cardiovascular disease in the women's health initiative cohorts. Archives of Internal Medicine 2009;169(3):294-304.
167. Ray AL, Semba RD, Walston J, Ferrucci L, Cappola AR, Ricks MO, et al.Low serum selenium and total carotenoids predict mortality among older women living in the community: the women's health and aging studies. Journal of Nutrition 2006;136(1):172-6.
168. Larsen EH. Prevention of cancer by intervention with Selenium (pilot) - PRECISE-PILOT. http://www.food.dtu.dk/Default.aspx?ID=20782 (accessed 6 April 2011).
169. MRC Clinical Trials Unit, ISRCTN64336220 . A randomised double-blind placebo-controlled cancer prevention trial with an estimated duration of 5 years with 52, 000 subjects recruited from the general populations of the UK, Denmark, Sweden, Finland and the United States. http://www.controlled-trials.com/ISRCTN64336220 (accessed 6 April 2011).
170. Rayman M, ISRCTN25193534 . UK prevention of cancer by intervention with selenium. http://www.controlled-trials.com/ISRCTN25193534/ (accessed 6 April 2011).
171. Rayman M, NCT00022165 . Selenium in the prevention of cancer. http://clinicaltrials.gov/ct2/show/NCT00022165. England, W12 ONN, United Kingdom: Hammersmith Hospital London, (accessed 6 April 2011).
172. Rendon RA, Fleshner N. Vitamin E, selenium and soy protein in preventing cancer in patients with high-grade prostate neoplasia. http://clinicaltrials.gov/ct2/show/NCT00064194. www.clinicaltrials.gov, (accessed 6 April 2011).
173. Steevens J, Schouten LJ, Driessen AL, Huysentruyt CJ, Keulemans YC, Goldbohm RA, et al.Toenail selenium status and the risk of Barrett's esophagus: the Netherlands Cohort Study. Cancer Causes Control 2010;21(12):2259-68.
174. Thompson CA, Habermann TM, Wang AH, Vierkant RA, Folsom AR, Ross JA, et al.Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin lymphoma: the Iowa Women's Health Study. International Journal of Cancer 2009;(epub ahead of print):doi 10.1002/ijc.24830. [DOI: 10.1002/ijc.24830]
175. Tsugane S, Hamada GS, Karita K, Tsubono Y, Laurenti R. Cancer patterns and lifestyle among Japanese immigrants and their descendants in the city of Sao Paulo, Brazil. Gann Monographs on Cancer Research 1996;44:43-50.
176. Ujiie S, Kikuchi H. The relation between serum selenium value and cancer in Miyagi, Japan: 5-year follow up study. Tohoku Journal of Experimental Medicine 2002;196(3):99-109.
177. van't Veer P, Strain JJ, Fernandez-Crehuet J, Martin BC, Thamm M, Kardinaal AF, et al.Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC). Cancer Epidemiology, Biomarkers & Prevention 1996;5(6):441-7.
178. van Noord PAH, van der Tweel I, Kaaks R, de Waard F. Selenium levels and subsequent colorectal cancers: the efficiency gain of a sequential test to a cohort-nested study with a 1:4 matching ratio. In: van Noord PAH editor(s). Selenium and Human Cancer Risk: Nail Keratin as a Tool in Metabolic Epidemiology. Amsterdam: Thesis Publishers, 1992:139-53.
179. van Noord PAH, Maas MJ, van der Tweel I, Collette C. Selenium and the risk of postmenopausal breast cancer in the DOM cohort. Breast Cancer Research and Treatment 1993;25(1):11-9.
180. Wallace K, Kelsey KT, Schned A, Morris JS, Andrew AS, Karagas MR. Selenium and risk of bladder cancer: a population-based case-control study. Cancer Prevention Research (Phila Pa) 2009;2(1):70-3.
181. Watters JL, Park Y, Hollenbeck A, Schatzkin A, Albanes D. Cigarette smoking and prostate cancer in a prospective US cohort study. Cancer Epidemiology, Biomarkers & Prevention 2009;18(9):2427-35.
182. Wright ME, Mayne ST, Stolzenberg-Solomon RZ, Li Z, Pietinen P, Taylor PR, et al.Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers. American Journal of Epidemiology 2004;160(1):68-76.
183. You WC, Li JY, Zhang L, Jin ML, Chang YS, Ma JL, et al.Etiology and prevention of gastric cancer: a population study in a high risk area of China. Chinese Journal of Digestive Diseases 2005;6(4):149-54.
184. Yuan JM, Gao YT, Ong CN, Ross RK, Yu MC. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma. JNCI Cancer Spectrum 2006;98(7):482-90.
185. Zeegers MP, Bryan RT, Langford C, Billingham L, Murray P, Deshmukh NS, et al.The West Midlands Bladder Cancer Prognosis Programme: rationale and design. BJU International 2010;705(6):784-8. [DOI: 10.1111/j.1464-410X.2009.08849.x]
186. Nomura AM, 5R01CA033644-19 . Cancer sero epidemiology among the Japanese in Hawaii. http://crisp.cit.nih.gov/ (accessed 12 January 2004).
187. Cheng KK, ISRCTN38534743 . Selenium supplementation for the prevention of hepatocellular carcinomas in HBsAg positive patients (pilot study). http://www.controlled-trials.com/isrctn/trial_print-friendly.asp?ISRCTN=38534743 (accessed 16 April 2004).
188. Cheng KK, ISRCTN13889738 . Bladder Cancer Prognosis Programme (incorporating SELENIB trial). http://www.controlled-trials.com/mrct/trial/232573/selenib (accessed 18 February 2009).
189. Eastern Cooperative Oncology Group. Selenium in preventing tumor growth in patients with previously resected stage I non-small cell lung cancer. http://clinicaltrials.gov/ct2/show/NCT00008385 (accessed 6 April 2011).
190. Eastern Cooperative Oncology Group, ECOG-5597 . Phase III randomized chemoprevention study of selenium in participants with previously resected stage I non-small cell lung cancer. http://www.cancer.gov/clinicaltrials/featured/trials/ecog-5598. Eastern Cooperative Oncology Group, (accessed 6 April 2011).
191. Karp DD. Phase III chemoprevention trial of selenium supplementation in persons with resected stage I non-small-cell lung cancer. Clinical Advances in Hematology and Oncology 2005;3(4):313-5.
192. Ahmann FR, 5R01CA077789-05 . Phase III Trial of Selenium for Prostate Cancer. http://crisp.cit.nih.gov/ (accessed 12 January 2004).
193. Ahmann, F . Phase III Randomized Study of Selenium for Prostate Cancer Prevention. http://www.cancer.gov./search/ViewClinicalTrials.aspx?cdrid=654651 (accessed 20 October 2009).
194. Clark LC, Marshall JR. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia. Urology 2001;57(4 Suppl 1):185-7.
195. Marshall JR. Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials. Nutrition and Cancer 2001;40(1):74-7.
196. Nelson MA, Reid M, Duffield-Lillico AJ, Marshall JR. Prostate cancer and selenium. The Urologic Clinics of North America 2002;29(1):67-70.
197. Stratton MS, Reid ME, Schwartzberg G, Minter FE, Monroe BK, Alberts DS, et al.Selenium and prevention of prostate cancer in high-risk men: the negative biopsy study. Anticancer Drugs 2003;14(8):589-94.
198. Arnaud J, Arnault N, Roussel AM, Bertrais S, Ruffieux D, Galan P, et al.Relationships between selenium, lipids, iron status and hormonal therapy in women of the SU.VI.M.AX cohort. Journal of Trace Elements in Medicine and Biology 2007;21(Suppl 1):66-9.
199. Arnaud J, de Lorgeril M, Akbaraly T, Salen P, Arnout J, Cappuccio FP, et al.Gender differences in copper, zinc and selenium status in diabetic-free metabolic syndrome European population - the IMMIDIET study. Nutrition, Metabolism and Cardiovascular Disease 2012;22(6):517-24.
200. Ashar BH. The dietary supplement health and education act: time for a reassessment. Archives of Internal Medicine 2010;170(3):261-3.
201. Ashton K, Hooper L, Harvey LJ, Hurst R, Casgrain A, Fairweather-Tait SJ. Methods of assessment of selenium status in humans: a systematic review. American Journal of Clinical Nutrition 2009;89(6):2025S-39S.
202. Barany E, Bergdahl IA, Bratteby LE, Lundh T, Samuelson G, Schutz A, et al.Trace elements in blood and serum of Swedish adolescents: relation to gender, age, residential area, and socioeconomic status. Environmental Research 2002;89(1):72-84.
203. Behne D, Gessner H, Kyriakopoulos A. Information on the selenium status of several body compartments of rats from the selenium concentrations in blood fractions, hair and nails. Journal of Trace Elements in Medicine and Biology 1996;103:174-9.
204. Behne D, Alber D, Kyriakopoulos S. Long-term selenium supplementation of humans: selenium status and relationships between selenium concentrations in skeletal muscle and indicator materials. Journal of Trace Elements in Medicine and Biology 2010;24(2):99-105.
205. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD004183.pub3]
206. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD007176]
207. Block E, Glass RS, Jacobsen NE, Johnson S, Kahakachchi C, Kaminski R, et al.Identification and synthesis of a novel selenium-sulfur amino acid found in selenized yeast: rapid indirect detection NMR methods for characterizing low-level organoselenium compounds in complex matrices. Journal of Agricultural and Food Chemistry 2004;52(12):3761-71.
208. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al.Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. Journal of the National Cancer Institute 1993;85(18):1483-92.
209. Bodnar M, Konieczka P, Namiesnik J. The properties, functions, and use of selenium compounds in living organisms. Journal of Environmental Science and Health, Part C, Environmental Carcinogenesis & Ecotoxicology Reviews 2012;30(3):225-52.
210. Brigo F, Storti M, Lochner P, Tezzon F, Nardone F. Selenium supplementation for primary prevention of cardiovascular disease: proof of no effectiveness. Nutrition, Metabolism & Cardiovascular Disease 2014;24(1):e2-3.
211. Brinkman M, Reulen RC, Kellen E, Buntinx F, Zeegers MP. Are men with low selenium levels at increased risk of prostate cancer?. European Journal of Cancer 2006;42(15):2463-71.
212. Bruhn RL, Stamer WD, Herrygers LA, Levine JM, Noecker RJ. Relationship between glaucoma and selenium levels in plasma and aqueous humour. British Journal of Ophthalmology 2009;93(9):1155-8.
213. Burri J, Haldimann M, Dudler V. Selenium status of the Swiss population: assessment and change over a decade. Journal of Trace Elements in Medicine and Biology 2008;22(2):112-9.
214. Chen X, Mikhail SS, Ding YW, Yang G, Bondoc F, Yang CS. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis 2000;21(8):1531-6.
215. Chintala S, Najrana T, Toth K, Cao S, Durrani FA, Pili R, et al.Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition. BMC Cancer 2012;12:293.
216. Combs GF Jr. Current evidence and research needs to support a health claim for selenium and cancer prevention. Journal of Nutrition 2005;135(2):343-7.
217. Combs GF Jr, Jackson MI, Watts JC, Johnson LK, Zeng H, Idso J, et al.Differential responses to selenomethionine supplementation by sex and genotype in healthy adults. British Journal of Nutrition 2012;107(10):1514-25.
218. Dalton SO, Schuz J, Engholm G, Johansen C, Kjaer SK, Steding-Jessen M, et al.Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: Summary of findings. European Journal of Cancer 2008;44(14):2074-85.
219. Davis CD, Tsuji PA, Milner JA. Selenoproteins and cancer prevention. Annual Review of Nutrition 2012;32:73-95.
220. Dennert G, Brinkman M, Vinceti M, Zeegers M, Zwahlen M, Horneber M. [P18-179] How global is our knowledge? Population diversity in observational studies on selenium and cancer risk. http://www.cochrane.org/colloquium/2008/virtual_posters/?poster=168 16th Cochrane Colloquium, Freiburg, 3-7 October 2008 (Poster).
221. Driscoll MS, Kwon EK, Skupsky H, Kwon SY, Grant-Kels JM. Nutrition and the deleterious side effects of nutritional supplements. Clinics in Dermatology 2010;28(4):371-9.
222. Duffield AJ, Thomson CD. A comparison of methods of assessment of dietary selenium intakes in Otago, New Zealand. British Journal of Nutrition 1999;82(2):131-8.
223. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. British Medical Journal 1998;316(7125):140-4.
224. Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE, et al.Selenium in human health and disease. Antioxidants & Redox Signaling 2011;14(7):1337-83.
225. Fan C, Chen J, Wang Y, Wong YS, Zhang Y, Zheng W, et al.Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway. Free Radical Biology & Medicine 2013;65C:305-16.
226. Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2013;159(12):824-34.
227. Gammelgaard B, Jackson MI, Gabel-Jensen C. Surveying selenium speciation from soil to cell--forms and transformations. Analytical and Bioanalytical Chemistry 2011;399(5):1743-63.
228. Gorlova OY, Zhang Y, Schabath MB, Lei L, Zhang Q, Amos CI, et al.Never smokers and lung cancer risk: a case-control study of epidemiological factors. International Journal of Cancer 2006;118(7):1798-804.
229. Guallar E, Stranges S, Mulrow C, Appel LJ, Miller ER III. Enough is enough: stop wasting money on vitamin and mineral supplements. Annals of Internal Medicine 2013;159(2):850-1.
230. Gundacker C, Komarnicki G, Zodl B, Forster C, Schuster E, Wittmann K. Whole blood mercury and selenium concentrations in a selected Austrian population: does gender matter?. The Science of the Total Environment 2006;372(1):76-86.
231. Haldimann M, Venner TY, Zimmerli B. Determination of selenium in the serum of healthy Swiss adults and correlation to dietary intake. Journal of Trace Elements in Medicine and Biology 1996;10(1):31-45.
232. Hall C. [Investigations on the direct and indirect genotoxicity of sodium seleniute and selenomethionine] [Untersuchungen zur direkten und indirekten Genotoxizität von Natriumselenit und Selenmethionin]. Univ Diss. Berlin, Germany: Technische Universität Berlin, 2008.
233. Hatfield DL, Yoo MH, Carlson BA, Gladyshev VN. Selenoproteins that function in cancer prevention and promotion. Biochimica et Biophysica Acta 2009;1790(11):1541-5.
234. Hatfield DL, Tsuji PA, Carlson BA, Gladyshev VN. Selenium and selenocysteine: roles in cancer, health, and development. Trends in Biochemical Sciences 2014;39(3):112-20.
235. Hazane-Puch F, Champelovier P, Arnaud J, Garrel C, Ballester B, Faure P, et al.Long-term selenium supplementation in HaCaT cells: importance of chemical form for antagonist (protective versus toxic) activities. Biological Trace Elements Research 2013;154(2):288-98.
236. Heck JA, Parka AS, Qiub J, Cockburnc M, Ritz B. Risk of leukemia in relation to exposure to ambient air toxics inpregnancy and early childhood. International Journal of Hygiene and Environmental Health 2014:(in press).
237. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al.The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine 2004;164(21):2335-42.
238. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327(7414):557-60.
239. Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. Journal of the Royal Statistical Society Series A (Statistics in Society) 2009;172(1):137-59.
240. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org 2011.
241. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al.Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. British Medical Journal 2011;343:d5928.
242. Hunter DJ, Morris JS, Chute CG, Kushner E, Colditz GA, Stampfer MJ, et al.Predictors of selenium concentration in human toenails. American Journal of Epidemiology 1990;132(1):114-22.
243. Hurst R, Collings R, Harvey LJ, King M, Hooper L, Bouwman J, et al.EURRECA-estimating selenium requirements for deriving dietary reference values. Critical Reviews in Food Science and Nutrition 2013;53(10):1077-96.
244. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al.GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet], 2013. http://globocan.iarc.fr/.
245. Institute of Medicine. Dietary reference intakes: elements. http://www.iom.edu/Object.File/Master/54/395/DRIs.Elements.pdf (accessed 18 May 2009).
246. Jablonska E, Gromadzinska J, Klos A, Bertrandt J, Skibniewska K, Darago A, et al.Selenium, zinc and copper in the Polish diet. Journal of Food Composition and Analysis 2013;31(2):259-65.
247. Jackson MI, Combs GF Jr. Selenium and anticarcinogenesis: underlying mechanisms. Current Opinion in Clinical Nutrition and Metabolic Care 2008;11(6):718-26.
248. Jaffé W. Selenio, un elemento esencial y toxico. Datos de Latinoamerica. Archivos Latinoamericanos de Nutrición 1992;42(2):90-3.
249. Jerome-Morais A, Diamond AM, Wright ME. Dietary supplements and human health: for better or for worse?. Molecular Nutrition & Food Research 2011;55(1):122-35.
250. Jossa F, Trevisan M, Krogh V, Farinaro E, Giumetti D, Fusco G, et al.Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis 1991;87(2-3):129-34.
251. Kafai MR, Ganji V. Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: third National Health and Nutrition Examination Survey, 1988-1994. Journal of Trace Elements in Medicine and Biology 2003;17(1):13-8.
252. Kandas NO, Randolph C, Bosland MC. Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations. Nutrition and Cancer 2009;61(2):251-64.
253. Kant AK, Graubard BI. Ethnicity is an independent correlate of biomarkers of micronutrient intake and status in American adults. Journal of Nutrition 2007;137(11):2456-63.
254. Karita K, Sasaki S, Ishihara J, Tsugane S. Validity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study to assess selenium intake: comparison with dietary records and blood levels. Journal of Epidemiology 2003;13(1 Suppl):S92-7.
255. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, et al.Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-smallcell lung cancer: ECOG 5597. Journal of Clinical Oncology 2013;31(33):4179-87.
256. Kim YY, Mahan DC. Comparative effects of high dietary levels of organic and inorganic selenium on selenium toxicity of growing-finishing pigs. Journal of Animal Science 2001;79(4):942-8.
257. Kim YW, Bae SM, Liu HB, Kim IW, Chun HJ, Ahn WS. Selenium enhances the efficacy of Radachlorin mediated-photodynamic therapy in TC-1 tumor development. Oncology Reports 2012;28(2):576-84.
258. Lawlor DA, Davey SG, Kundu D, Bruckdorfer KR, Ebrahim S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?. Lancet 2004;363(9422):1724-7.
259. Longnecker MP, Stram DO, Taylor PR, Levander OA, Howe M, Veillon C, et al.Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 1996;7(4):384-90.
260. Marik PE, Flemmer M. Do dietary supplements have beneficial health effects in industrialized nations: what is the evidence?. JPEN. Journal of Parenteral and Enteral Nutrition 2012;36(2):159-68.
261. Martinez ME, Jacobs ET, Baron JA, Marshall JR, Byers T. Dietary supplements and cancer prevention: balancing potential benefits against proven harms. Journal of the National Cancer Institute 2012;104(10):732-9.
262. Mayne ST, Ferrucci LM, Cartmel B. Lessons learned from randomized clinical trials of micronutrient supplementation for cancer prevention. Annual Review of Nutrition 2012;32:369-90.
263. McNaughton SA, Marks GC, Green AC. Role of dietary factors in the development of basal cell cancer and squamous cell cancer of the skin. Cancer Epidemiology, Biomarkers & Prevention 2005;14(7):1596-607.
264. Morris JS, Crane SB. Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor. Nutrients 2013;5(4):1024-57.
265. Moyad MA. Heart healthy=prostate healthy: SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms?. Asian Journal of Andrology 2012;14(2):243-4.
266. Murphy SP, Wilkens LR, Hankin JH, Foote JA, Monroe KR, Henderson BE, et al.Comparison of two instruments for quantifying intake of vitamin and mineral supplements: a brief questionnaire versus three 24-hour recalls. American Journal of Epidemiology 2002;156(7):669-75.
267. National Toxicology Program. Selenium sulfide. Report on carcinogens: carcinogen profiles/U.S. Dept. of Health and Human Services, Public Health Service, National Toxicology Program 2011;12:376-7.
268. Nishino Y, Tsubono Y, Tsuji I, Komatsu S, Kanemura S, Nakatsuka H, et al.Passive smoking at home and cancer risk: a population-based prospective study in Japanese nonsmoking women. Cancer Causes and Control 2001;12(9):797-802.
269. Niskar AS, Paschal DC, Kieszak SM, Flegal KM, Bowman B, Gunter EW, et al.Serum selenium levels in the US population: Third National Health and Nutrition Examination Survey, 1988-1994. Biological Trace Element Research 2003;91(1):1-10.
270. Novoselov SV, Calvisi DF, Labunskyy VM, Factor VM, Carlson BA, Fomenko DE, et al.Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene 2005;24(54):8003-11.
271. Office of Dietary Supplements, NIH Clinical Centers, National Institutes of Health. Dietary Supplement Fact Sheet: Selenium. http://ods.od.nih.gov/factsheets/selenium.asp (accessed 18 May 2009).
272. Ovaskainen ML, Virtamo J, Alfthan G, Haukka J, Pietinen P, Taylor PR, et al.Toenail selenium as an indicator of selenium intake among middle-aged men in an area with low soil selenium. The American Journal of Clinical Nutrition 1993;57(5):662-5.
273. Panter KE, Hartley WJ, James LF, Mayland HF, Stegelmeier BL, Kechele PO. Comparative toxicity of selenium from seleno-DL-methionine, sodium selenate, and Astragalus bisulcatus in pigs. Fundamental and Applied Toxicology 1996;32(2):217-23.
274. Pearce N. The globalization of epidemiology: introductory remarks. International Journal of Epidemiology 2004;33(5):1127-31.
275. Pestitschek M, Sonneck-Koenne C, Zakavi SR, Li S, Knoll P, Mirzaei S. Selenium intake and selenium blood levels: a novel food frequency questionnaire. Wiener Klinische Wochenschrift 2013;125(5-6):160-4.
276. Pildal J, Hrobjartsson A, Jorgensen KJ, Hilden J, Altman DG, Gotzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. International Journal of Epidemiology 2007;36(4):847-57.
277. Pounis G, Costanzo S, Persichillo M, de Curtis A, Sieri S, Vinceti M, et al.Moli-sani Project Investigators. Mushroom and dietary selenium intakes in relation to fasting glucose levels in a free-living Italian adult population: the Moli-sani Project. Diabetes & Metabolism 2014;40:34-42; Vol. 40, issue 1:34-42.
278. Qu CX, Kamangar F, Fan JH, Yu B, Sun XD, Taylor PR, et al.Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China. Journal of the National Cancer Institute 2007;99(16):1240-7.
279. Rapiti E, Fioretta G, Schaffar R, Neyroud-Caspar I, Verkooijen HM, Schmidlin F, et al.Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis. Cancer 2009;115(23):5556-65.
280. Rayman MP. The importance of selenium to human health. Lancet 2000;356(9225):233-41.
281. Rayman MP. The use of high-selenium yeast to raise selenium status: how does it measure up?. British Journal of Nutrition 2004;92(4):557-73.
282. Rayman MP, Infante HG, Sargent M. Food-chain selenium and human health: spotlight on speciation. British Journal of Nutrition 2008;100(2):238-53.
283. Rayman MP. Food-chain selenium and human health: emphasis on intake. British Journal of Nutrition 2008;100(2):254-68.
284. Rayman MP. Selenium and human health. Lancet 2012;379(9822):1256-68.
285. Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S. Selenium supplementation for the primary prevention of cardiovascular disease. The Cochrane Database of Systematic Reviews 2013;1:CD009671.
286. Rocourt CR, Cheng WH. Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance?. Nutrients 2013;5(4):1349-65.
287. Rodriguez Rodriguez EM, Sanz Alaejos MT, Diaz Romero C. Urinary selenium status of healthy people. European Journal of Clinical Chemistry and Clinical Biochemistry 1995;33(3):127-33.
288. Rose AH, Bertino P, Hoffmann FW, Gaudino G, Carbone M, Hoffmann PR. Increasing dietary selenium elevates reducing capacity and ERK activation associated with accelerated progression of select mesothelioma tumors. The American Journal of Pathology 2014:(in press).
289. Sacco JE, Dodd KW, Kirkpatrick SI, Tarasuk V. Voluntary food fortification in the United States: potential for excessive intakes. European Journal of Clinical Nutrition 2013;67(6):592-7.
290. Satia JA, King IB, Morris JS, Stratton K, White E. Toenail and plasma levels as biomarkers of selenium exposure. Annals of Epidemiology 2006;16(1):53-8.
291. Schrauzer GN, White DA, Schneider CJ. Cancer mortality correlation studies - III: statistical associations with dietary selenium intakes. Biological Chemistry 1977;7(1):23-31.
292. Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Canadian Medical Association Journal 1969;100(14):682.
293. Slavik P, Illek J, Brix M, Hlavicova J, Rajmon R, Jilek F. Influence of organic versus inorganic dietary selenium supplementation on the concentration of selenium in colostrum, milk and blood of beef cows. Acta Veterinaria Scandinavica 2008;50:43.
294. Smith AM, Chang MP, Medeiros LC. Generational differences in selenium status of women. Biological Trace Element Research 2000;75(1-3):157-65.
295. Solovyev N, Berthele A, Michalke B. Selenium speciation in paired serum and cerebrospinal fluid samples. Analytical and Bioanalytical Chemistry 2013;405(6):1875-84.
296. Sonaa E, Usha S, Ja In J. An ex vivo study of selenium, genistein on the morphological and nuclear changes in anticancer drug-induced apoptosis in human peripheral blood lymphocytes. Biofactors 2013;39(3):279-93.
297. Steen A, Strom T, Bernhoft A. Organic selenium supplementation increased selenium concentrations in ewe and newborn lamb blood and in slaughter lamb meat compared to inorganic selenium supplementation. Acta Veterinaria Scandinavica 2008;50:7.
298. Steinbrenner H, Speckmann B, Sies H. Toward understanding success and failures in the use of selenium for cancer prevention. Antioxidants & Redox Signaling 2013;19(2):181-91.
299. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, et al.Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Annals of Internal Medicine 2007;147(4):217-23.
300. Stranges S, Sieri S, Vinceti M, Grioni S, Guallar E, Laclaustra M, et al.A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health 2010;10:564.
301. Su YP, Tang JM, Tang Y, Gao HY. Histological and ultrastructural changes induced by selenium in early experimental gastric carcinogenesis. World Journal of Gastroenterology 2005;11(29):4457-60.
302. Swanson CA, Longnecker MP, Veillon C, Howe M, Levander OA, Taylor PR, et al.Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in a seleniferous area. The American Journal of Clinical Nutrition 1990;52(5):858-62.
303. Tiwary AK, Stegelmeier BL, Panter KE, James LF, Hall JO. Comparative toxicosis of sodium selenite and selenomethionine in lambs. Journal of Veterinary Diagnostic Investigation 2006;18(1):61-70.
304. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Hermus RJ, Sturmans F. Predictors of toenail selenium levels in men and women. Cancer Epidemiology, Biomarkers & Prevention 1993;2(2):107-12.
305. Vinceti M, Rothman KJ, Bergomi M, Borciani N, Serra L, Vivoli G. Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Cancer Epidemiology, Biomarkers & Prevention 1998;7(10):853-6.
306. Vinceti M, Rovesti S, Bergomi M, Vivoli G. The epidemiology of selenium and human cancer. Tumori 2000;86(2):105-18.
307. Vinceti M, Nacci G, Rocchi E, Cassinadri T, Vivoli R, Marchesi C, et al.Mortality in a population with long-term exposure to inorganic selenium via drinking water. Journal of Clinical Epidemiology 2000;53(10):1062-8.
308. Vinceti M, Wei ET, Malagoli C, Bergomi M, Vivoli G. Adverse health effects of selenium in humans. Reviews on Environmental Health 2001;16(4):233-51.
309. Vinceti M, Maraldi T, Bergomi M, Malagoli C. Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry. Reviews on Environmental Health 2009;24(3):231-48.
310. Vinceti M, Crespi CM, Malagoli C, Bottecchi I, Ferrari A, Sieri S, et al.A case-control study of the risk of cutaneous melanoma associated with three selenium exposure indicators. Tumori 2012;98(3):287-95.
311. Vinceti M, Crespi CM, Bonvicini F, Malagoli C, Ferrante M, Marmiroli S, et al.The need for a reassessment of the safe upper limit of selenium in drinking water. The Science of the Total Environment 2013;443:633-42.
312. Vinceti M, Crespi CM, Malagoli C, Del Giovane C, Krogh V. Friend or foe? The current epidemiologic evidence on selenium and human cancer risk. Journal of Environmental Science and Health, Part C, Environmental Carcinogenesis & Ecotoxicology Reviews 2013;31(4):305-41.
313. Vinceti M, Solovyev N, Mandrioli J, Crespi CM, Bonvicini F, Arcolin E, et al.Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. Neurotoxicology 2013;38:25-32.
314. Vinceti M, Mandrioli J, Borella P, Michalke B, Tsatsakis A, Finkelstein Y. Selenium neurotoxicity in humans: bridging laboratory and epidemiologic studies. Toxicology Letters 2013 (in press).
315. Waters DJ, Chiang EC, Cooley DM, Morris JS. Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Mutation Research 2004;551(1-2):91-107.
316. Waters DJ, Shen S, Kengeri SS, Chiang EC, Combs GF, Morris JS, Bostwick DG. Proceedings of the 10th International Symposium on Selenium in Biology and Medicine. Berlin: Deutsche Forschungsgemeinschaft, 2013:62.
317. Weekley CM, Aitken JB, Finney L, Vogt S, Witting PK, Harris HH. Selenium metabolism in cancer cells: the combined application of XAS and XFM techniques to the problem of selenium speciation in biological systems. Nutrients 2013;5(5):1734-56.
318. Wells GA, Shea B, ÓConnell D, Peterson J, Welch V, Losos M, et al.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Ottawa, (accessed 1 April 2004).
319. Whanger PD. Selenium and its relationship to cancer: an update. British Journal of Nutrition 2004;91(1):11-28.
320. Joint FAO/WHO Expert Consultation on Human Vitamin, Mineral Requirements. Vitamin and mineral requirements in human nutrition: report of a joint FAO/WHO expert consultation, Bangkok, Thailand, 21-30 September 1998. http://whqlibdoc.who.int/publications/2004/9241546123.pdf. World Health Organization (WHO), 2004.
321. WHO . Are the number of cancer cases increasing or decreasing in the world?. http://www.who.int/features/qa/15/en/index.html (accessed 9 September 2008).
322. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. British Medical Journal 2008;336(7644):601-5.
323. Zeng H, Uthus EO, Combs GF Jr. Mechanistic aspects of the interaction between selenium and arsenic. Journal of Inorganic Biochemistry 2005;99(6):1269-74.
324. Zwolak I, Zaporowska H. Selenium interactions and toxicity: a review. Cell Biology and Toxicology 2012;28(1):31-46.
325. Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers MP, Horneber M. Selenium for preventing cancer. Cochrane Database of Systematic Reviews 2011, Issue 5. [DOI: 10.1002/14651858.CD005195]